InterPAD是植物化学品和抗癌药物之间的药物相互作用的数据库
Aili Zhang1,2, Xueni Sun2, Qibiao Wu1
1State Key Laboratory of Quality Research in Chinese Medicines, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, People's Republic of China.
Scientific reports
|July 9, 2025
概括
InterPAD数据库汇编了植物化合物 (植物化学物质) 和抗癌药物之间的相互作用. 本资源有助于理解联合癌症疗法和开发新的治疗策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
- 在瘤学瘤学.
背景情况:
- 药用植物是药物发现的重要来源,特别是在癌症治疗中.
- 植物化学物质有可能增强传统的癌症治疗方法,克服单一治疗的局限性.
- 了解植物化学药物相互作用是优化联合癌症治疗的关键.
研究的目的:
- 开发InterPAD,一个全面的数据库,详细介绍植物化学品和抗癌药物之间的相互作用.
- 为了解这些相互作用的作用机制和治疗效果提供见解.
- 促进植物化学品融入现代癌症治疗方案.
主要方法:
- 从已发表的文献中,手动整理了331种植物化学物质和244种抗癌药物之间的1055种相互作用.
- 整合了680种药用植物,619种调节分子和74种癌症类型的数据.
- 为研究人员开发在线可访问的数据库.
主要成果:
- InterPAD是第一个全面研究各种癌症类型的植物化学药物相互作用的数据库.
- 数据库详细介绍了协同作用和对抗作用,强调了生物影响.
- 它采用"多个调节分子和多个信号通路"的机制性洞察力框架.
结论:
- InterPAD是促进癌症研究和改善治疗策略的宝贵资源.
- 该数据库有助于更深入地了解联合癌症治疗中的植物化学物质.
- 它支持开发新的,有效的癌症治疗方案.
相关概念视频
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Combined Effects of Drugs: Antagonism
9.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.3K
Drug-Receptor Interactions
6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Factors Affecting Protein-Drug Binding: Drug Interactions
286
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
286
Drug-Receptor Interaction: Antagonist
3.5K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
3.5K


